Kailera Therapeutics, Inc. KLRA 深 沪
已收盘 09-25 16:00:00 美东时间
11.215
-0.765
-6.39%
华盛通- 最 高12.325
- 今 开11.80
- 成交量 172.27万股
- 最 低 11.10
- 昨 收 11.98
- 总市值 14.54亿
- 52周最高 28.2271
- 市盈率 静 --
- 换手率 1.33%
- 52周最低 11.10
- 委 比 29.98%
- 总股本 1.30亿
- 历史最高 28.2271
- 量 比 0.88
- 振 幅 10.23%
- 历史最低 11.10
- 每 手 1
- 风险率 3.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jim Cramer Recommends Buying This Energy Stock, Calling It ‘Very Inexpensive’
On CNBC’s “Mad Money Lightning Round,” Jim Cramer recommended buying Texas Pacific Land Corporation (NYSE:TPL), adding that the stock is going higher and is a “very inexpensive” one. On the earnings front, Texas Pacific Land reported worse-than-expected second-quarter results on Aug. 5. Cramer said ...
09-11 20:49
Kailera Therapeutics Q2 EPS $(1.09) Misses $(0.74) Estimate
Kailera Therapeutics (NASDAQ:KLRA) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.74) by 47.3 percent.
08-13 04:39
Kailera Therapeutics Q1 EPS $(3.65) Misses $(0.68) Estimate as R&D Spend Jumps to $70.9M
Kailera Therapeutics (NASDAQ:KLRA) reported quarterly losses of $(3.65) per share which missed the analyst consensus estimate of $(0.68) by 444.78 percent as R&D spend Jumps to $70.9M.
05-27 04:50
This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst
William Blair gives Kailera Therapeutics ($KLRA) an Outperform rating. Learn why analysts see a competitive edge in their GLP-1 assets.
05-14 02:43
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
JP Morgan Initiates Coverage On Kailera Therapeutics with Overweight Rating, Announces Price Target of $30
JP Morgan analyst Hardik Parikh initiates coverage on Kailera Therapeutics (NASDAQ:KLRA) with a Overweight rating and announces Price Target of $30.
05-12 22:29
Kailera Therapeutics shares are trading higher amid post-IPO volatility.
Kailera Therapeutics shares are trading higher amid post-IPO volatility.
04-20 22:56
美股收盘：纳指13连涨！追平1992年以来最长连涨纪录；大型科技股悉数走强，特斯拉涨超3%，苹果涨超2%
伊朗开放霍尔木兹海峡，纳指涨超1.5%录得13连涨！追平1992年以来最长连涨纪录；大型科技股悉数走强，特斯拉涨超3%，苹果涨超2%；稀土概念股CRML大涨超35%>>
04-18 09:07
募资6.25亿美元创五年之最 减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克
Kailera Therapeutics Inc.通过扩大首次公开发行(IPO)规模，成功募资6.25亿美元，创下2021年以来美国生物科技领域规模最大的IPO纪录。
04-17 11:33
减肥药公司Kailera Therapeutics(KLRA.US)IPO定价14-16美元/股 拟周五登陆纳斯达克
Kailera Therapeutics于周一公布其首次公开募股(IPO)条款。
04-14 15:19
